Long-term outcomes after deep venous thrombosis of the lower extremities
Open Access
- 1 February 1998
- journal article
- research article
- Published by SAGE Publications in Vascular Medicine
- Vol. 3 (1) , 57-60
- https://doi.org/10.1177/1358836x9800300112
Abstract
Few natural history studies are available which describe long-term outcomes after venous thromboembolism. However, symptomatic deep-vein thrombosis (DVT) of the lower extremities carries a high risk for recurrent venous thromboembolism that persists for many years. This risk is higher among patients with permanent risk factors including inherited abnormalities of hemostasis than among patients who have suffered trauma or who are postoperative. The development of recurrent ipsilateral DVT carries a high risk for severe post-thrombotic syndrome, an otherwise rare problem in patients with a first episode of DVT adequately treated with anticoagulant drugs and wearing vascular compression stockings. Long-term survival following DVT is generally good in the absence of malignancy. Carefully designed randomized trials are needed to determine whether chronic anticoagulation can reduce further the risks of recurrent DVT and symptoms of post-thrombotic syndrome.Keywords
This publication has 28 references indexed in Scilit:
- Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosisPublished by Elsevier ,1997
- The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)New England Journal of Medicine, 1997
- The Long-Term Clinical Course of Acute Deep Venous ThrombosisAnnals of Internal Medicine, 1996
- Prospective 12-Year Follow-up Study of Clinical and Hemodynamic Sequelae After Deep Vein Thrombosis in Low-Risk Patients (Zürich Study)Circulation, 1996
- Factor V Leiden and Risks of Recurrent Idiopathic Venous ThromboembolismCirculation, 1995
- After a first episode of venous thromboembolismBMJ, 1995
- The Optimal Duration of Anticoagulant Therapy for Venous ThrombosisNew England Journal of Medicine, 1995
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- The Postphlebitic SyndromeClinics in Chest Medicine, 1984